These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 2454238
1. Human cytokines, tumor necrosis factor, and interferons: gene cloning, animal studies, and clinical trials. Bollon AP, Berent SL, Torczynski RM, Hill NO, Lemeshev Y, Hill JM, Jia FL, Joher A, Pichyangkul S, Khan A. J Cell Biochem; 1988 Apr; 36(4):353-67. PubMed ID: 2454238 [Abstract] [Full Text] [Related]
2. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin. Satoh M, Inagawa H, Shimada Y, Soma G, Oshima H, Mizuno D. J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926 [Abstract] [Full Text] [Related]
3. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines. Totpal K, Aggarwal BB. Cancer Res; 1991 Aug 15; 51(16):4266-70. PubMed ID: 1651157 [Abstract] [Full Text] [Related]
4. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor. Onozaki K, Urawa H, Tamatani T, Iwamura Y, Hashimoto T, Baba T, Suzuki H, Yamada M, Yamamoto S, Oppenheim JJ. J Immunol; 1988 Jan 01; 140(1):112-9. PubMed ID: 3275716 [Abstract] [Full Text] [Related]
5. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells. Drescher KM, Whittum-Hudson JA. Invest Ophthalmol Vis Sci; 1996 Oct 01; 37(11):2302-12. PubMed ID: 8843914 [Abstract] [Full Text] [Related]
6. Apoptosis of cultured mouse luteal cells induced by tumor necrosis factor-alpha and interferon-gamma. Jo T, Tomiyama T, Ohashi K, Saji F, Tanizawa O, Ozaki M, Yamamoto R, Yamamoto T, Nishizawa Y, Terada N. Anat Rec; 1995 Jan 01; 241(1):70-6. PubMed ID: 7879925 [Abstract] [Full Text] [Related]
7. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines. Marley GM, Doyle LA, Ordóñez JV, Sisk A, Hussain A, Yen RW. Cancer Res; 1989 Nov 15; 49(22):6232-6. PubMed ID: 2553249 [Abstract] [Full Text] [Related]
8. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells. Gemlo BT, Palladino MA, Jaffe HS, Espevik TP, Rayner AA. Cancer Res; 1988 Oct 15; 48(20):5864-7. PubMed ID: 3139285 [Abstract] [Full Text] [Related]
9. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats. Debs RJ, Fuchs HJ, Philip R, Montgomery AB, Brunette EN, Liggitt D, Patton JS, Shellito JE. J Immunol; 1988 May 15; 140(10):3482-8. PubMed ID: 3283235 [Abstract] [Full Text] [Related]
10. Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor. Beresini MH, Lempert MJ, Epstein LB. J Immunol; 1988 Jan 15; 140(2):485-93. PubMed ID: 3121746 [Abstract] [Full Text] [Related]
11. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state. Yamamoto N, Zou JP, Li XF, Takenaka H, Noda S, Fujii T, Ono S, Kobayashi Y, Mukaida N, Matsushima K. J Immunol; 1995 Mar 01; 154(5):2281-90. PubMed ID: 7868900 [Abstract] [Full Text] [Related]
12. Preclinical approaches to the treatment of metastatic disease: therapeutic properties of rH TNF, rM IFN-gamma, and rH IL-2. Talmadge JE, Black PL, Tribble H, Pennington R, Bowersox O, Schneider M, Phillips H. Drugs Exp Clin Res; 1987 Mar 01; 13(6):327-37. PubMed ID: 3115744 [Abstract] [Full Text] [Related]
13. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis. Moriconi F, Raddatz D, Ho NA, Yeruva S, Dudas J, Ramadori G. Transl Res; 2007 Oct 01; 150(4):223-32. PubMed ID: 17900510 [Abstract] [Full Text] [Related]
16. Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF. Philip R. J Immunol; 1988 Feb 15; 140(4):1345-9. PubMed ID: 2449501 [Abstract] [Full Text] [Related]
18. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses. Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG. Exp Eye Res; 1997 Dec 15; 65(6):781-9. PubMed ID: 9441701 [Abstract] [Full Text] [Related]
19. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1. Morikawa K, Fidler IJ. J Biol Response Mod; 1989 Apr 15; 8(2):206-18. PubMed ID: 2499665 [Abstract] [Full Text] [Related]
20. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes. Batten P, Yacoub MH, Rose ML. Immunology; 1996 Jan 15; 87(1):127-33. PubMed ID: 8666424 [Abstract] [Full Text] [Related] Page: [Next] [New Search]